These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 5577943)
21. Effect of orotic acid in lysine deficient rats. Viviani R; Sechi AM; Moruzzi G Int Z Vitaminforsch; 1969; 39(1):95-7. PubMed ID: 5784670 [No Abstract] [Full Text] [Related]
22. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716 [TBL] [Abstract][Full Text] [Related]
23. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins]. Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876 [TBL] [Abstract][Full Text] [Related]
24. Pattern of serum amino acids in patients with liver cirrhosis. Influence of shunt surgery and transesophageal sclerotherapy. Joelsson B; Hultberg B; Alwmark A; Gullstrand P; Bengmark S Scand J Gastroenterol; 1984 Jun; 19(4):547-51. PubMed ID: 6611579 [TBL] [Abstract][Full Text] [Related]
25. Effect of arginine and glutamate on the removal of ammonia from the blood in normal and cirrhotic patients. BESSMAN SP; SHEAR S; FITZGERALD J N Engl J Med; 1957 May; 256(20):941-3. PubMed ID: 13451972 [No Abstract] [Full Text] [Related]
26. Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK). Belvisi A; Matergi M; Fici F Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):142-6. PubMed ID: 7068288 [TBL] [Abstract][Full Text] [Related]
27. Long-term oral lysine supplementation in lysinuric protein intolerance. Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331 [TBL] [Abstract][Full Text] [Related]
28. [Effects of urea-cycle amino-acid and glutamic acid on hyperammonemia]. Kurimura O; Seki K; Omura I; Miyazaki H; Okuhiro S Iryo; 1966 Apr; 20(4):305-9. PubMed ID: 5974187 [No Abstract] [Full Text] [Related]
29. [Clinical study of AICA orotate in hepatitis and cirrhosis]. Chanoine F Acta Gastroenterol Belg; 1969; 32(4-5):383-95. PubMed ID: 4927897 [No Abstract] [Full Text] [Related]
30. [Treatment of cirrhosis of the liver by a combination of Lipovitan and orotic acid (author's transl)]. Fassati P; Spízek J; Fassati M Cas Lek Cesk; 1980 Jul; 119(27-28):770-3. PubMed ID: 7428000 [No Abstract] [Full Text] [Related]
31. [Action of ascorbic acid on ammonemia, especially in cirrhotics]. Warter J; Schirardin H; Bauer M C R Seances Soc Biol Fil; 1966; 160(4):868-72. PubMed ID: 4224025 [No Abstract] [Full Text] [Related]
32. [Comparative actions of ascorbic acid, reduced glutathione and NADH on ammoniemia in cirrhotic patients]. Warter J; Schirardin H; Bauer M; Metais P C R Seances Soc Biol Fil; 1966; 160(7):1515-8. PubMed ID: 4289544 [No Abstract] [Full Text] [Related]
33. [Influence of Fuzheng Huayu Capsules on abnormal amino acids spectrum in chronic liver diseases]. Huang YK; Zhao CQ; Hu YY; Xue HM; Liu C; Liu P Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):230-1. PubMed ID: 15760567 [No Abstract] [Full Text] [Related]
34. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138 [TBL] [Abstract][Full Text] [Related]
35. Plasma amino acid response to protein ingestion in patients with liver cirrhosis. Marchesini G; Bianchi G; Zoli M; Dondi C; Forlani G; Melli A; Bua V; Vannini P; Pisi E Gastroenterology; 1983 Aug; 85(2):283-90. PubMed ID: 6345256 [TBL] [Abstract][Full Text] [Related]
36. Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation. Shih VE; Efron ML; Moser HW Am J Dis Child; 1969 Jan; 117(1):83-92. PubMed ID: 5782534 [No Abstract] [Full Text] [Related]
37. Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection. Si J; Cao Q; Gao M; Fang L; Qian G; Wang Y Chin Med J (Engl); 2000 Dec; 113(12):1080-1. PubMed ID: 11776140 [TBL] [Abstract][Full Text] [Related]
38. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326 [TBL] [Abstract][Full Text] [Related]
39. Hyperglycinemia with ketoacidosis and leukopenia. Metabolic studies on the nature of the defect. Soriano JR; Taitz LS; Finberg L; Edelmann CM Pediatrics; 1967 Jun; 39(6):818-28. PubMed ID: 6026548 [No Abstract] [Full Text] [Related]
40. Ammonia and uric acid formation after rapid intravenous fructose administration to healthy subjects and patients with compensated cirrhosis of the liver. Brodan V; Brodanová M; Kuhn E; Filip J; Pechar J Nutr Metab; 1975; 19(5-6):233-41. PubMed ID: 785305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]